Please assess the completion status of the following clinical trial:

Trial Title: Norepinephrine Consumption After Prophylactic Ondansetron

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA physical status I-II patients~* Between the ages of 18 and 40 years~* Scheduled for elective caesarean section with spinal anesthesia~Exclusion Criteria:~* History of hypertension~* History of severe hepato-renal disease,~* sensitivity or contraindication to ondansetron,~* Drug or alcohol abuse~* Contraindication to regional anesthesia.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Ondansetron (Type: EXPERIMENTAL): None
- Saline (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).